A146 ASSESSMENT OF THE USE OF THERAPEUTIC DRUG MONITORING OF INFLIXIMAB DURING MAINTENANCE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE

BACKGROUND: Infliximab (IFX) was proven effective in the induction and maintenance of remission in inflammatory bowel diseases (IBD) in both children and adults. There is a significant number of individual who lose response to the medication. Measurable IFX drug levels correlate with clinical respon...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Can Assoc Gastroenterol
Asıl Yazarlar: Chavannes, M, Gervais, F, Robitaille, R, Marchand, V, Deslandres, C, Jantchou, P
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2018
Konular:
Poster Presentations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507680/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.147
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller